|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.63 USD | -0.72% |
|
+25.06% | +15.88% |
| Apr. 17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
| Apr. 17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
IGM Biosciences, Inc. will be reducing its workforce by approximately 22%. As a result of these actions, the company expected to extend its cash runway into the second quarter of 2026.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.88% | 568M | |
| -3.46% | 102B | |
| +1.41% | 96.09B | |
| +2.13% | 22.28B | |
| -15.84% | 21.4B | |
| -9.21% | 18.14B | |
| -39.98% | 17.02B | |
| -14.65% | 16.09B | |
| +4.39% | 13.83B | |
| +31.35% | 11.97B |
IGM BIOSCIENCES, INC. 
